Searchable abstracts of presentations at key conferences in endocrinology

ea0035p1035 | Thyroid (non-cancer) | ECE2014

Results of preventive radioiodine therapy in euthyroid patients with history of hyperthyroidism prior to administration of amiodarone with permanent atrial fibrillation (preliminary study)

Czarnywojtek Agata , Wolinski Kosma , Gut Pawel , Czepczynski Rafal , Plazinska Maria Teresa , Kunikowska Jolanta , Kobylecka Malgorzata , Miechowicz Izabela , Krolicki Leszek , Ruchala Marek

Introduction: Radioiodine (RAI) therapy is a standard procedure in therapy of hyperthyroidism. However, the use of RAI in euthyroid patients requiring chronic administration of amiodarone (AM), in a case of lacking efficacy of other antiarrhythmic drugs might be controversial.Objective: The aim of the study was to assess the safety and efficacy of an AM therapy prior to treatment with radioiodine therapy in euthyroid patients with permanent atrial fibril...

ea0014p131 | (1) | ECE2007

Results 90Y-DOTATATE therapy in patients with neuroendocrine tumours (NETs) - own experience

Kunikowska Jolanta , Hubalewska-Dydejczyk Alicja , Sowa-Staszczak Anna , Krolicki Leszek , Ochman Pawel , Mikolajczak Renata , Pawlak Dariusz , Kobylecka Malgorzata , Maczewska Joanna , Huszno Bohdan

In the 1980 s the discovery of expression of somatostatin receptors on NET cells made the use of somatostatin analogues in diagnosis and therapy possible.The aim: Of the study was to assess response of targeted radio-nuclide therapy with radio-labelled somatostatin analogue 90Y-[DOTA0,D-Phe1,Tyr3]-octreotate (DOTATATE) in treatment of disseminated NETs.Material and methods: 12 patients (a...